Streetbeat News

Earnings

MOVE

Movano Health's Evie Ring, a consumer wellness device, has exceeded FDA accuracy guidelines in its second hypoxia trial, achieving a root mean square error average of 2.46% against the FDA guidance of 3.5% for SpO2. The trial used the commercial production model of the Evie Ring, which will be submitted to the FDA and sold under the brand name Evie Med. The device outperformed two hospital-grade reference pulse oximeters in the study.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 6:28 am

AFYA

Afya reported its Q4 adjusted earnings per share (EPS) at R$1.79, an increase from R$1.38 year-over-year (YoY). The company's revenue for the quarter was R$729.5 million, up from R$669.68 million YoY.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 5:50 am

JBL

Jabil Inc. (NYSE:JBL) is anticipated to report lower Q2 earnings with an expected EPS of $1.66, down from $1.88 year-over-year, and revenue of $6.89 billion. The company declared a quarterly dividend of 8 cents per share. Shares fell 0.9% to $147.46 recently. Analysts from Goldman Sachs, Stifel, JP Morgan, Barclays, and Raymond James have provided varied ratings and price targets for JBL, reflecting a mix of optimism and caution.

Portfolio Pulse from Avi Kapoor

March 15, 2024 | 5:47 am

TSLA

Ross Gerber, a significant investor in Tesla Inc (NASDAQ:TSLA), has suggested that Tesla's recent stock decline could be reversed by a change in CEO Elon Musk's behavior or his replacement. The stock has fallen over 36% this year due to poor earnings, a lackluster product lineup, and broader market challenges. Wells Fargo downgraded Tesla's stock with a price target of $125, citing a 'growth company with no growth'. Despite this, Dan Ives of Wedbush Securities predicts a 77% rebound in Tesla's stock within the next 12 months, suggesting improvements to Musk's compensation and share control as solutions.

Portfolio Pulse from Benzinga Neuro

March 15, 2024 | 2:17 am

TSNDF

TerrAscend Corp. (OTCQX:TSNDF) reported a 28% year-over-year revenue increase for 2023, totaling $317.3 million, driven by sales in Maryland and New Jersey. Q4 revenue rose 25.5% to $86.6 million. Despite a Q4 GAAP net loss of $41.8 million due to non-cash impairment charges, the company achieved positive cash flow for the first time in its history, with $31.1 million from continuing operations and $23.4 million in free cash flow. The company's gross profit margin improved significantly, reaching 50.3% for the year. TerrAscend aims for expansion in 2024, leveraging its strong operational foundation.

Portfolio Pulse from Maureen Meehan

March 15, 2024 | 2:13 am

VSTM

Verastem (NASDAQ:VSTM) reported Q4 earnings with a significant miss on estimated earnings by -77.0%, posting an EPS of $-1.1 against an estimate of $-0.62. Revenue remained unchanged from the same period last year. This follows a previous quarter where the company beat EPS estimates but experienced a 6.0% drop in share price the next day.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:55 pm

MGTX

MeiraGTx Holdings (NASDAQ:MGTX) reported Q4 earnings with an EPS of $0.42, surpassing the estimated -$0.11 by 482%. Revenue increased by $7.33 million from the previous year. Despite missing EPS estimates last quarter, the share price increased by 2% the following day.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:50 pm

FMST

HYMC

IE

X

Ivanhoe Electric Inc. (IE) and its subsidiary announced advancements in exploration software, enhancing geophysical models with machine learning. President Biden plans to oppose Nippon Steel's acquisition of U.S. Steel (X), emphasizing the importance of keeping U.S. Steel American-owned. Hycroft Mining (HYMC) reported significant 2023 operating results, including high-grade silver discoveries. Foremost Lithium (FMST) completed part of its private placements, raising $1.629 million for exploration and corporate needs.

Portfolio Pulse from Austin DeNoce

March 14, 2024 | 9:48 pm

HSCS

Heart Test Laboratories (NASDAQ:HSCS) reported Q3 earnings, beating estimates with an EPS of $-0.03 versus the expected $-0.06, and revenue increased by $12 thousand year-over-year. Despite missing EPS estimates last quarter, the share price increased by 12.0% the following day.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:45 pm

GETY

Getty Images Holdings Inc. (NYSE:GETY) reported Q4 sales of $225.94 million, surpassing analyst estimates and showing a slight year-over-year decrease. Editorial revenue fell due to Hollywood strikes, but annual subscription revenue increased. The company expects FY 2024 revenue to be slightly below consensus estimates but remains optimistic about returning to growth and maintaining profitability. Shares rose 8.74% in after-hours trading.

Portfolio Pulse from Erica Kollmann

March 14, 2024 | 9:36 pm